Fig. 1: Low levels of serum sPD-L1 indicated more severe disease and predicted worse prognosis in patients with direct ARDS.
From: Soluble PD-L1 improved direct ARDS by reducing monocyte-derived macrophages
A Serum sPD-L1 levels in healthy controls (n = 10), Non-ARDS patients with mechanical ventilation (n = 20) and ARDS patients (n = 44). B sPD-L1 levels of survivors (n = 20) and non-survivors (n = 10) of direct ARDS. C Correlations between APACHEII score and serum sPD-L1 levels in patients with direct ARDS (n = 30). D Correlations between oxygenation index and the levels of serum sPD-L1 in patients with direct ARDS (n = 30). *P < 0.05, **P < 0.01, ***P < 0.001, P value was determined by unpaired t test. ####P < 0.01, P value was determined by Man–Whitney test.
